Glaucoma, Vision & Longevity: Supplements & Science
Discover the latest science on glaucoma, vision, and longevity. Each episode explores evidence-based supplements for eye health, healthy aging, and lifespan extension. Original articles backed by real scientific research. All source links available at visualfieldtest.com, where you can also take a free visual field test online. Subscribe for weekly insights on glaucoma treatment, glaucoma prevention, vision supplements, and longevity research that could protect your sight and extend your healthspan.
MEDICAL DISCLAIMER:
This podcast is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. The content presented should not replace professional medical consultation.
Glaucoma is a serious condition that can lead to permanent vision loss. Never stop or modify prescribed treatments without consulting your ophthalmologist or healthcare provider.
The supplements and research discussed are for informational purposes only. Individual results may vary, and supplements are not FDA-approved to treat, cure, or prevent any disease.
Always consult a qualified healthcare professional before starting any new supplement regimen, especially if you have existing eye conditions or are taking medications.
The visual field test available at visualfieldtest.com is a screening tool only and does not replace comprehensive eye exams by a licensed professional.
Glaucoma, Vision & Longevity: Supplements & Science
What Causes Glaucoma
This audio article is from VisualFieldTest.com.
Read the full article here: https://visualfieldtest.com/en/what-causes-glaucoma
Test your visual field online: https://visualfieldtest.com
Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support
Excerpt:
Elevated Eye Pressure: The Main Driver of Glaucoma Glaucoma often begins when aqueous humor (the eye’s clear fluid) builds up, raising intraocular pressure (IOP). Normally this fluid drains freely from the front of the eye through the trabecular meshwork and a secondary uveoscleral pathway. If these drainage channels become blocked or less efficient – due to age-related changes or other damage – fluid cannot exit fast enough and pressure rises (). This chronic pressure pushes on the optic nerve at the back of the eye. Over time, the nerve fibers (which carry vision to the brain) are compressed and die, leading to the classic “cupping” of glaucoma and blind spots. For example, mutations in the MYOC gene cause a misfolded protein in the trabecular meshwork that raises IOP (), directly illustrating how fluid outflow problems lead to glaucoma.Normal-Tension Glaucoma: Beyond Pressure Not all glaucoma patients have high eye pressure. In normal-tension glaucoma (NTG), IOP remains in the normal range, yet optic nerve damage still occurs. Research suggests reduced blood flow to the optic nerve plays a key role. Insufficient eye or brain blood supply (for instance from vascular disease, nocturnal low blood pressure or migraine) starves nerve fibers of oxygen () (). In support, studies show NTG patients often have signs of poor circulation or systemic blood pressure dips, making the optic nerve more vulnerable. Another theory is low cerebrospinal fluid (CSF) pressure around the optic nerve may increase the pressure difference across the nerve head, squeezing it even when eye pressure is “normal.” Indeed, NTG patients were found to have lower CSF pressure than healthy people (). In short, NTG likely involves a “bad blood flow/bad fluid environment” effect: optic nerve cells are inherently sensitive, and factors like low blood or CSF pressure, plus other insults, can injure them even without high IOP () ().Genetic Causes of Glaucoma Family history is one of the strongest risks for glaucoma (). Specific gene mutations have been identified for different glaucoma types. For primary open-angle glaucoma (POAG), three genes stand out: MYOC, OPTN, and TBK1. MYOC (first discovered glaucoma gene) accounts for about 3–4% of typical open-angle cases with high IOP (). Mutant MYOC protein clogs the drainage meshwork, raising pressure (). The other genes, OPTN and TBK1, each cause roughly 1% of cases, usually in NTG (normal-pressure) patients (). These genes normally help cells clear waste and regulate survival, so when mutated they may impair cell housekeeping (autophagy) and trigger nerve-cell failure (). For congenital glaucoma (seen in babies and young children), the CYP1B1 gene is a leading cause (). CYP1B1 is involved in eye development; recessive mutations disrupt the drainage system before birth, so pressure builds early (). Other genes tied to childhood glaucoma include FOXC1 and PITX2, which guide eye/front structure development – mutations in these (often in Axenfeld-Rieger syndrome) lead to abnormal angles and drainage block () (). Rare TEK/ANGPT1 mutations (involved in forming fluid channels during development) also cause juvenile glaucoma (). For angle-closure glaucoma, the genetics are more complex and less clear-cut. This form depends on eye shape (shallow front chamber) more than one gene. Some studies have found key variants